Mechanisms of Disease: pathogenesis of nonalcoholic fatty liver disease
- PMID: 16265100
- DOI: 10.1038/ncpgasthep0084
Mechanisms of Disease: pathogenesis of nonalcoholic fatty liver disease
Abstract
Nonalcoholic fatty liver disease (NAFLD) is associated with the metabolic syndrome. The metabolic syndrome is characterized by insulin resistance, which is produced by a complex interaction between genetic factors, macronutrient intake and lifestyle that alters the cytokine profile, cell biology and biochemical milieu of the liver, adipose tissue and striated muscle. The resultant disequilibrium in lipid homeostasis causes triglycerides to accumulate in the liver. An increase in oxidative stress, due to the generation of reactive oxygen species as a result of mitochondrial abnormalities and induction of the cytochrome P-450 system could be one mechanism by which the nonalcoholic fatty liver develops into nonalcoholic steatohepatitis. The pathogenesis of cytologic ballooning and Mallory body formation and their role in NAFLD remain to be defined. In addition, inflammation and fibrosis are likely to be secondary to hepatocyte injury and death.
Similar articles
-
Abnormalities of lipid metabolism in nonalcoholic fatty liver disease.Semin Liver Dis. 2008 Nov;28(4):351-9. doi: 10.1055/s-0028-1091979. Epub 2008 Oct 27. Semin Liver Dis. 2008. PMID: 18956291 Review.
-
Interaction of metabolic syndrome, nonalcoholic fatty liver disease and chronic hepatitis C.Expert Rev Gastroenterol Hepatol. 2008 Apr;2(2):207-15. doi: 10.1586/17474124.2.2.207. Expert Rev Gastroenterol Hepatol. 2008. PMID: 19072356 Review.
-
The metabolic syndrome and nonalcoholic fatty liver disease.Panminerva Med. 2006 Mar;48(1):41-8. Panminerva Med. 2006. PMID: 16633331 Review.
-
Pathology of nonalcoholic fatty liver disease.Am J Clin Pathol. 2007 Nov;128(5):837-47. doi: 10.1309/RTPM1PY6YGBL2G2R. Am J Clin Pathol. 2007. PMID: 17951208 Review.
-
Fatty liver and the metabolic syndrome.Curr Opin Gastroenterol. 2007 Mar;23(2):193-8. doi: 10.1097/MOG.0b013e32801421a9. Curr Opin Gastroenterol. 2007. PMID: 17268250 Review.
Cited by
-
New insights into the role of macrophages in adipose tissue inflammation and Fatty liver disease: modulation by endogenous omega-3 Fatty Acid-derived lipid mediators.Front Immunol. 2011 Oct 5;2:49. doi: 10.3389/fimmu.2011.00049. eCollection 2011. Front Immunol. 2011. PMID: 22566839 Free PMC article.
-
Ketogenic essential amino acids modulate lipid synthetic pathways and prevent hepatic steatosis in mice.PLoS One. 2010 Aug 10;5(8):e12057. doi: 10.1371/journal.pone.0012057. PLoS One. 2010. PMID: 20706589 Free PMC article.
-
The balance of protein farnesylation and geranylgeranylation during the progression of nonalcoholic fatty liver disease.J Biol Chem. 2020 Apr 10;295(15):5152-5162. doi: 10.1074/jbc.REV119.008897. Epub 2020 Mar 5. J Biol Chem. 2020. PMID: 32139507 Free PMC article. Review.
-
Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future.World J Gastroenterol. 2014 Aug 21;20(31):10851-63. doi: 10.3748/wjg.v20.i31.10851. World J Gastroenterol. 2014. PMID: 25152587 Free PMC article. Review.
-
Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet.J Lipid Res. 2008 May;49(5):1068-76. doi: 10.1194/jlr.M800042-JLR200. Epub 2008 Jan 28. J Lipid Res. 2008. PMID: 18227531 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources